Skip to content
Search

Latest Stories

Chickenpox vaccine sales up by over 400 per cent at Superdrug

Superdrug has reported more than 400 per cent spike in sale of the chickenpox vaccine in the UK.

To protect children against the disease during chickenpox season, nearly nine out of 10 patients (87 per cent) have taken their wards under the age of five for vaccination in the last eight weeks.


Chickenpox can be a seasonal disease with children usually catching it in the winter and spring, with UK peaks often between March and May.

The last two years of spending time in and out of various lockdowns have meant less interaction between people, and so less transmission across the general population.

Caris Newson, head of healthcare services at Superdrug, said: “One of the knock-on effects of Covid is that people have a greater awareness and understanding of the benefits that vaccines can offer.

"We launched the chickenpox vaccination service five years ago in 2017 and it’s now that we’re beginning to see greater interest in how it can support family health. In fact, our fully qualified nurses have told us that they’ve had more parents ask about the chickenpox vaccination service, and word of mouth has then spread amongst parents and schools.”

NHS advises that anyone with chickenpox needs to stay away from school, nursery or work until all the spots have formed a scab. This is usually for five days after the spots have appeared.

Dr Sara Kayat, Superdrug’s medical ambassador, added: “Chickenpox is a highly contagious viral infection, and whilst it tends to be a mild condition lasting one to two weeks, it can be very uncomfortable and in some rare cases can be severe. By having the chickenpox vaccine, you are likely to become immune to developing chickenpox, and if you do still get it, the symptoms are often milder, with fewer blisters and mild or no fevers.”

The vaccination is available at £70 per dose, and two doses -- four to eight weeks apart -- are recommended to give heightened immune protection.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less